DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE | A207825 | PHARMOBEDIENT CONSULTING LLC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Escher Fund for Autism - Citizen Petition FDA-2013-P-0522 · 6 docket documents Jill Escher, filing on behalf of the Escher Fund for Autism, submitted this citizen petition under 21 C.F.R. 10.30 on April 26, 2013, requesting that the FDA revoke its March 2013 approval of Diclegis (doxylamine succinate and pyridoxine hydrochloride) as a Category A pregnancy drug pending fetal ge | 505(q) | 2013-05-17 | Denied | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.